Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.67 |
| ▸ | RXFP1 | Q9HBX9 | 4/20 | 0.67 |
| ▸ | PTGES | O14684 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1718426 | 0.95 | MAPT (0.62) | MAPTRXFP1PTGESPOLBGAA | |
| SCHEMBL1717682 | 0.95 | RXFP1 (0.67) | MAPTRXFP1PTGESPOLBGAA | |
| SCHEMBL1718328 | 0.91 | MAPT (0.62) | MAPTRXFP1PTGESPOLBGAA | |
| SCHEMBL1718865 | 0.90 | PTGES (0.69) | MAPTRXFP1PTGESGAAL3MBTL1 | |
| SCHEMBL1720133 | 0.89 | RXFP1 (0.71) | MAPTRXFP1PTGESPOLBMEN1 | |
| SCHEMBL1719295 | 0.87 | RXFP1 (0.65) | MAPTRXFP1PTGESPOLBGAA | |
| SCHEMBL1719692 | 0.87 | PTGES (0.66) | MAPTRXFP1PTGESGAAL3MBTL1 | |
| SCHEMBL5658010 | 0.85 | RXFP1 (0.59) | MAPTRXFP1POLBGAAL3MBTL1 | |
| SCHEMBL1719597 | 0.85 | MAPT (0.60) | MAPTRXFP1PTGESPOLBGAA | |
| SCHEMBL1718002 | 0.85 | KMT2A (0.65) | MAPTRXFP1POLBGAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1506196-B1 | PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS | ICAGEN INC (US) | 2012-01-18 | — | — | EP | claimed |
| EP-1506196-B1 | PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS | ICAGEN INC (US) | 2012-01-18 | — | — | EP | disclosed |